Ken Griffin Paratek Pharmaceuticals, Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.67 - $2.51 $269,330 - $404,802	161,276 Added 385.06%	203,159 $379,000
Q3 2022 Nov 14, 2022	SELL	$1.96 - $2.93 $113,638 - $169,878	-57,979 Reduced 58.06%	41,883 $108,000
Q2 2022 Aug 15, 2022	SELL	$1.73 - $3.09 $19,306 - $34,484	-11,160 Reduced 10.05%	99,862 $193,000
Q1 2022 May 16, 2022	SELL	$2.94 - $4.77 $172,360 - $279,646	-58,626 Reduced 34.56%	111,022 $330,000
Q4 2021 Feb 14, 2022	BUY	$4.07 - $5.3 $578,790 - $753,707	142,209 Added 518.27%	169,648 $761,000
Q3 2021 Nov 15, 2021	SELL	$4.7 - $7.24 $75 - $115	-16 Reduced 0.06%	27,439 $133,000
Q2 2021 Aug 16, 2021	SELL	$6.81 - $10.93 $143,588 - $230,459	-21,085 Reduced 43.44%	27,455 $187,000
Q4 2020 Feb 16, 2021	BUY	$4.58 - $7.14 $58,935 - $91,877	12,868 Added 36.07%	48,540 $303,000
Q2 2020 Aug 14, 2020	BUY	$2.97 - $5.22 $20,439 - $35,924	6,882 Added 23.9%	35,672 $186,000
Q1 2020 May 15, 2020	SELL	$2.67 - $4.97 $146,807 - $273,270	-54,984 Reduced 65.63%	28,790 $91,000
Q4 2019 Feb 14, 2020	BUY	$2.93 - $4.5 $1,640 - $2,520	560 Added 0.67%	83,774 $338,000
Q3 2019 Nov 14, 2019	SELL	$3.08 - $5.76 $95,590 - $178,767	-31,036 Reduced 27.16%	83,214 $359,000
Q2 2019 Aug 14, 2019	BUY	$3.47 - $6.32 $26,507 - $48,278	7,639 Added 7.17%	114,250 $456,000
Q1 2019 May 15, 2019	SELL	$5.36 - $7.24 $30,294 - $40,920	-5,652 Reduced 5.03%	106,611 $0
Q4 2018 Feb 14, 2019	BUY	$4.8 - $11.6 $284,020 - $686,383	59,171 Added 111.45%	112,263 $575,000
Q3 2018 Nov 13, 2018	SELL	$9.05 - $10.95 $2.05 Million - $2.49 Million	-226,971 Reduced 81.04%	53,092 $0
Q2 2018 Aug 10, 2018	BUY	$10.2 - $13.9 $1.32 Million - $1.8 Million	129,212 Added 85.66%	280,063 $0
Q1 2018 May 11, 2018	BUY	$12.65 - $18.85 $1.5 Million - $2.24 Million	118,679 Added 368.89%	150,851 $1.96 Million
Q4 2017 Feb 09, 2018	SELL	$17.45 - $25.6 $1.07 Million - $1.57 Million	-61,505 Reduced 65.66%	32,172 $576,000
Q3 2017 Nov 09, 2017	BUY	$18.9 - $28.2 $1.77 Million - $2.64 Million	93,677	93,677 $2.35 Million

Others Institutions Holding PRTK

# of Institutions

Shares Held

1.54M

Call Options Held

Put Options Held

View Full List

About Paratek Pharmaceuticals, Inc.

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

More about PRTK

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account